Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency

Journal of Clinical Immunology

Volumn 29, Issue 6, 2009, Pages 777-785

  Mohammadi, Javad ^a   Liu, Chonghai ^a   Aghamohammadi, Asghar ^b   Bergbreiter, Astrid ^c   Du, Likun ^a   Lu, Jiayi ^a   Rezaei, Nima ^b   Amirzargar, Ali Akbar ^d   Moin, Mostafa ^b   Salzer, Ulrich ^c   Pan Hammarström, Qiang ^a   Hammarström, Lennart ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF FREIBURG   (Germany)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Common variable immunodeficiency; Human; Immunoglobulins; Mutation; TACI

Indexed keywords

APRIL PROTEIN; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

ARTICLE; B LYMPHOCYTE; C104R GENE; C172Y GENE; CAUCASIAN; CELL DIFFERENTIATION; CELL LINE; CLINICAL ARTICLE; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; FAMILY; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE DOSAGE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INTRON; IRAN; POPULATION; PRIORITY JOURNAL; PROTEIN BINDING; TACI GENE;

B-LYMPHOCYTES; CELL DIFFERENTIATION; COHORT STUDIES; COMMON VARIABLE IMMUNODEFICIENCY; FAMILY HEALTH; FEMALE; GENE DOSAGE; HOMOZYGOTE; HUMANS; IRAN; MALE; MUTATION; PEDIGREE; PROTEIN BINDING; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 72849116620     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-009-9317-5     Document Type: Article

References (30)

1. H Chapel M Lucas M Lee J Bjorkander D Webster B Grimbacher C Fieschi V Thon MR Abedi L Hammarstrom 2008 Common variable immunodeficiency disorders: division into distinct clinical phenotypes Blood 112 277 86 10.1182/blood-2007- 11-124545 1:CAS:528:DC%2BD1cXos1Citr0%3D 18319398
2. C Cunningham-Rundles C Bodian 1999 Common variable immunodeficiency: clinical and immunological features of 248 patients Clin Immunol 92 34 48 10.1006/clim.1999.4725 1:STN:280:DyaK1Mzktl2nuw%3D%3D 10413651 (Pubitemid 29315984)
3. Hammarstrom L, Smith CI. Genetic approach to common variable immunodeficiency and IgA deficiency. In: Ochs H, Smith E, Puck J, editors. Primary immunodeficiency disease, a molecular and genetic approach. Oxford: Oxford University Press; 2007. p. 313-25.
4. Q Pan-Hammarstrom L Hammarstrom 2008 Antibody deficiency diseases Eur J Immunol 38 327 33 10.1002/eji.200737927 18200502
5. L Mellemkjaer L Hammarstrom V Andersen J Yuen C Heilmann T Barington J Bjorkander JH Olsen 2002 Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study Clin Exp Immunol 130 495 500 10.1046/j.1365-2249.2002.02004.x 1:STN:280:DC%2BD38jis1Gktg%3D%3D 12452841 (Pubitemid 35418334)
6. B Grimbacher A Hutloff M Schlesier E Glocker K Warnatz R Drager H Eibel B Fischer AA Schaffer HW Mages RA Kroczek HH Peter 2003 Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency Nat Immunol 4 261 8 10.1038/ni902 1:CAS:528:DC%2BD3sXhsVGitrs%3D 12577056 (Pubitemid 36322136)
7. E Castigli SA Wilson L Garibyan R Rachid F Bonilla L Schneider RS Geha 2005 TACI is mutant in common variable immunodeficiency and IgA deficiency Nat Genet 37 829 34 10.1038/ng1601 1:CAS:528:DC%2BD2MXmsFKlsr0%3D 16007086 (Pubitemid 41077108)
8. U Salzer HM Chapel AD Webster Q Pan-Hammarstrom A Schmitt-Graeff M Schlesier HH Peter JK Rockstroh P Schneider AA Schaffer L Hammarstrom B Grimbacher 2005 Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans Nat Genet 37 820 8 10.1038/ng1600 1:CAS:528:DC%2BD2MXmsFKlsr4%3D 16007087 (Pubitemid 41077107)
9. Warnatz K, Salzer U, Gutenberger S. Finally found: human BAFF-R deficiency causes CVID. In: XIth meeting of the European Society for Immunodeficiencies, Versailles; 2004.
10. MC van Zelm I Reisli M van der Burg D Castano CJ van Noesel MJ van Tol C Woellner B Grimbacher PJ Patino JJ van Dongen JL Franco 2006 An antibody-deficiency syndrome due to mutations in the CD19 gene N Engl J Med 354 1901 12 10.1056/NEJMoa051568 16672701 (Pubitemid 43872691)
11. MC van Zelm J Smet F Mascart B Adam L Schandené F Janssen A Ferster JJ van Dongen M van der Burg 2008 Antibody-deficiency and acute nephritic syndrome in a patient with homozygous disruption of the CD81 gene Clin Exp Immunol 154 1 209
12. H Sekine RC Ferreira Q Pan-Hammarstrom RR Graham B Ziemba SS de Vries J Liu K Hippen T Koeuth W Ortmann A Iwahori MK Elliott S Offer C Skon L Du J Novitzke AT Lee N Zhao JD Tompkins D Altshuler PK Gregersen C Cunningham-Rundles RS Harris C Her DL Nelson L Hammarstrom GS Gilkeson TW Behrens 2007 Role for Msh5 in the regulation of Ig class switch recombination Proc Natl Acad Sci U S A 104 7193 8 10.1073/pnas.0700815104 1:CAS:528:DC%2BD2sXls1Gns70%3D 17409188 (Pubitemid 47186031)
13. J Moreaux FW Cremer T Reme M Raab K Mahtouk P Kaukel V Pantesco J De Vos E Jourdan A Jauch E Legouffe M Moos G Fiol H Goldschmidt JF Rossi D Hose B Klein 2005 The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature Blood 106 1021 30 10.1182/blood-2004-11-4512 1:CAS:528:DC%2BD2MXntVSmsro%3D 15827134 (Pubitemid 41076449)
14. GU von Bulow JM van Deursen RJ Bram 2001 Regulation of the T-independent humoral response by TACI Immunity 14 573 82 10.1016/S1074-7613(01)00130-3 (Pubitemid 32520868)
15. M Yan H Wang B Chan M Roose-Girma S Erickson T Baker D Tumas IS Grewal VM Dixit 2001 Activation and accumulation of B cells in TACI-deficient mice Nat Immunol 2 638 43 10.1038/89790 1:CAS:528:DC%2BD3MXltFSlur4%3D 11429549 (Pubitemid 32677632)
16. D Seshasayee P Valdez M Yan VM Dixit D Tumas IS Grewal 2003 Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor Immunity 18 279 88 10.1016/S1074-7613(03)00025-6 1:CAS:528:DC%2BD3sXhvFegurg%3D 12594954 (Pubitemid 36263002)
17. Q Pan-Hammarstrom U Salzer L Du J Bjorkander C Cunningham-Rundles DL Nelson C Bacchelli HB Gaspar S Offer TW Behrens B Grimbacher L Hammarstrom 2007 Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency Nat Genet 39 429 30 10.1038/ng0407-429 17392797 (Pubitemid 46514756)
18. U Salzer C Bacchelli S Buckridge Q Pan-Hammarstrom S Jennings V Lougaris A Bergbreiter T Hagena J Birmelin A Plebani AD Webster HH Peter D Suez H Chapel A McLean-Tooke GP Spickett S Anover-Sombke HD Ochs S Urschel BH Belohradsky S Ugrinovic DS Kumararatne TC Lawrence AM Holm JL Franco I Schulze P Schneider EM Gertz AA Schaffer L Hammarstrom AJ Thrasher HB Gaspar B Grimbacher 2009 Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes Blood 113 1967 76 10.1182/blood-2008-02-141937 1:CAS:528: DC%2BD1MXivVaqsbY%3D 18981294
19. L Zhang L Radigan U Salzer TW Behrens B Grimbacher G Diaz J Bussel C Cunningham-Rundles 2007 Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes J Allergy Clin Immunol 120 1178 85 10.1016/j.jaci.2007.10.001 1:CAS:528:DC%2BD2sXht1KkurzO 17983875 (Pubitemid 350047480)
20. U Hannelius CM Lindgren E Melen A Malmberg U von Dobeln J Kere 2005 Phenylketonuria screening registry as a resource for population genetic studies J Med Genet 42 e60 10.1136/jmg.2005.032987 1:STN:280:DC%2BD2MrisV2jtQ%3D%3D 16199543
21. K Ingold A Zumsteg A Tardivel B Huard QG Steiner TG Cachero F Qiang L Gorelik SL Kalled H Acha-Orbea PD Rennert J Tschopp P Schneider 2005 Identification of proteoglycans as the APRIL-specific binding partners J Exp Med 201 1375 83 10.1084/jem.20042309 1:CAS:528:DC%2BD2MXktVCmtb0%3D 15851487 (Pubitemid 40664082)
22. Q Pan Y Lindersson P Sideras L Hammarstrom 1997 Structural analysis of human gamma 3 intervening regions and switch regions: implication for the low frequency of switching in IgG3-deficient patients Eur J Immunol 27 2920 6 10.1002/eji.1830271126 1:CAS:528:DyaK2sXnt1Ojsb0%3D 9394819 (Pubitemid 27478363)
23. A Aghamohammadi A Farhoudi M Moin N Rezaei A Kouhi Z Pourpak N Yaseri M Movahedi M Gharagozlou F Zandieh F Yazadni S Arshi I Mohammadzadeh BM Ghazi M Mahmoudi S Tahaei A Isaeian 2005 Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency Clin Diagn Lab Immunol 12 825 32 1:CAS:528:DC%2BD2MXmslGjt70%3D 16002630
24. JR Darce BK Arendt X Wu DF Jelinek 2007 Regulated expression of BAFF-binding receptors during human B cell differentiation J Immunol 179 7276 86 1:CAS:528:DC%2BD2sXhtlajt7%2FN 18025170
25. V Ramensky P Bork S Sunyaev 2002 Human non-synonymous SNPs: server and survey Nucleic Acids Res 30 3894 900 10.1093/nar/gkf493 1:CAS:528: DC%2BD38Xms1Klt7k%3D 12202775
26. Z Wang J Moult 2001 SNPs, protein structure, and disease Hum Mutat 17 263 70 10.1002/humu.22 11295823 (Pubitemid 32268400)
27. PY Chou GD Fasman 1974 Prediction of protein conformation Biochemistry 13 222 45 10.1021/bi00699a002 1:CAS:528:DyaE2cXmslKitg%3D%3D 4358940
28. SG Hymowitz DR Patel HJ Wallweber S Runyon M Yan J Yin SK Shriver NC Gordon B Pan NJ Skelton RF Kelley MA Starovasnik 2005 Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding J Biol Chem 280 7218 27 10.1074/jbc.M411714200 1:CAS:528:DC%2BD2MXhsV2qu7Y%3D 15542592 (Pubitemid 40341279)
29. L Garibyan AA Lobito RM Siegel ME Call KW Wucherpfennig RS Geha 2007 Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID) J Clin Invest 117 1550 7 10.1172/JCI31023 1:CAS:528:DC%2BD2sXmsVWkur8%3D 17492055 (Pubitemid 46871339)
30. D Detkova N Martinez-Pomar J Arostegui D Escobar J Ferrer A Serra A Vidaller P Soler M Vendrell A Alvarez J De Gracia I Caragol T Espanol J Yague N Matamoros M Hernandez 2008 Role of the p.C104R variant of TNFRSF13B encoding TACI in patients with common variable immunodeficiency Clin Exp Immunol 154 1 158